Q4 and Full Year 2025 Operational and Financial Results: Q4 Net Income of $38.1M ($0.70 per Share) vs. Net Loss of $8.2M ($0.16 per Share) in Q4 2024; Advancing Ke…

(NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along ...

Visa Inc. (V) Presents at Wolfe Research FinTech Forum Transcript

Darrin Peller Wolfe Research, LLC. Guys, why don't we jump in? Thank you again for everyone for joining us. Day 2 of the Wolfe Fintech Forum. Really happy to have Visa with us. An ...
BMJ Open

Home-based physical activity intelligent programme for patients with lower extremity Ilizarov: a study protocol for a randomised controlled trial

Introduction Lower extremity Ilizarov surgery, a common procedure for correcting bone deformities, is often associated with reduced physical activity (PA) and functional decline. The home-based PA ...